Researcher.Life Logo

Breast Cancer: Targets and Therapy : Impact Factor & More

eISSN: 1179-1314pISSN: 1179-1314
JournalOpen Access

Key Metrics

CiteScore
5.9
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.51
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Breast Cancer: Targets and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Breast Cancer: Targets and Therapy

Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability
  • 2 Apr 2026
  • Breast Cancer : Targets and Therapy
Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review
  • 1 Apr 2026
  • Breast Cancer : Targets and Therapy
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer
  • 1 Apr 2026
  • Breast Cancer : Targets and Therapy
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)
Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)
Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability
  • 2 Apr 2026
  • Breast Cancer : Targets and Therapy
Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review
  • 1 Apr 2026
  • Breast Cancer : Targets and Therapy
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer
  • 1 Apr 2026
  • Breast Cancer : Targets and Therapy
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)
Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.
  • 1 Apr 2026
  • Breast cancer (Dove Medical Press)

FAQs on Breast Cancer: Targets and Therapy